SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-065520
Filing Date
2015-11-16
Accepted
2015-11-16 07:30:54
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v420794_10q.htm 10-Q 534853
2 EXHIBIT 10.8 v420794_ex10-8.htm EX-10.8 167069
3 EXHIBIT 31.1 v420794_ex31-1.htm EX-31.1 8358
4 EXHIBIT 31.2 v420794_ex31-2.htm EX-31.2 8336
5 EXHIBIT 32.1 v420794_ex32-1.htm EX-32.1 3809
6 EXHIBIT 32.2 v420794_ex32-2.htm EX-32.2 3812
  Complete submission text file 0001144204-15-065520.txt   5643451

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT xtnt-20150930.xml EX-101.INS 1158931
8 XBRL TAXONOMY EXTENSION SCHEMA xtnt-20150930.xsd EX-101.SCH 53811
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xtnt-20150930_cal.xml EX-101.CAL 60318
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xtnt-20150930_def.xml EX-101.DEF 349886
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE xtnt-20150930_lab.xml EX-101.LAB 433948
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xtnt-20150930_pre.xml EX-101.PRE 408799
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 151231644
SIC: 2836 Biological Products, (No Diagnostic Substances)